Breast-feeding after Transplantation.

Publication/Presentation Date

11-1-2014

Abstract

Transplantation affords recipients the potential for a full life and, for some, parenthood. Female transplant recipients must continue to take immunosuppression during pregnancy and breast-feeding. This article reviews case and series reports regarding breast-feeding in those taking transplant medications. Avoidance of breast-feeding has been the customary advice because of the potential adverse effects of immunosuppressive exposure on the infant. Subsequent studies have demonstrated that not all medication exposure translates to risk for the infant, that the exposure in utero is greater than via breast milk and that no lingering effects due to breast-feeding have been found to date in infants who were breast-fed while their mothers were taking prednisone, azathioprine, cyclosporine, and/or tacrolimus. Thus, except for those medications where clinical information is inadequate (mycophenolic acid products, sirolimus, everolimus, and belatacept), the recommendation for transplant recipients regarding breast-feeding has evolved into one that is cautiously optimistic.

Volume

28

Issue

8

First Page

1163

Last Page

1173

ISSN

1532-1932

Disciplines

Nephrology | Obstetrics and Gynecology | Other Medical Specialties | Surgery

PubMedID

25271063

Department(s)

Department of Surgery, Department of Surgery Faculty

Document Type

Article

Link to Full Text

Share

COinS